USP <797> CSP Categories 1, 2 and 3: The Main Differences

USP <797> organizes compounded sterile preparations (CSPs) into Category 1, Category 2, and Category 3. The categories connect the preparation environment and quality controls with the maximum supported beyond-use date (BUD). They are not simple labels for low, medium, and high risk, and a longer BUD requires stronger controls and evidence under the current chapter.

Start with what is being categorized

A compounded sterile preparation is a sterile drug preparation produced through compounding. USP <797> sets practice standards for how these preparations are made, including personnel competency, environmental conditions, process controls, labeling, and documentation. The category is one part of that system. It helps determine which controls apply and what BUD may be assigned; it does not certify that a preparation is safe by itself.

The three categories in plain language

Category 1 allows a comparatively shorter BUD under the chapter’s default framework and can be prepared in a segregated compounding area (SCA) with a suitable primary engineering control (PEC). Category 2 can use a cleanroom suite or other permitted conditions and allows longer BUDs when all applicable requirements are met. Category 3 supports the longest BUD framework but comes with the most demanding environmental monitoring, process verification, and quality requirements. Exact limits and conditions belong to the current official chapter and facility procedures.

Category is not a substitute for aseptic technique

A controlled room cannot compensate for poor hand hygiene, untrained staff, contaminated supplies, or a broken procedure. Likewise, strong technique does not erase an unsuitable environment. The chapter treats these as linked controls: facilities qualify spaces and equipment, personnel demonstrate competency, and each preparation follows written procedures. A technician should never infer that a familiar recipe may be assigned a longer BUD simply because it was prepared in a cleanroom.

Why environment and BUD connect

Every additional hour or day before use creates more time for contamination or a quality problem to matter. USP therefore conditions BUD on preparation conditions and controls. Category 1 may be appropriate for a preparation needed soon, while the extra controls required for longer BUDs support storage and later use. A BUD is the deadline for starting administration, not the manufacturer’s expiration date and not automatically the time an infusion must finish. Confirm the distinction in the current USP FAQ and pharmacy policy.

How to reason through a scenario

Suppose a question says a CSP is prepared in a PEC in an unclassified SCA and asks what category may apply. USP’s public FAQ confirms Category 1 CSPs can be prepared in a PEC in an SCA or cleanroom suite, provided all other applicable requirements are met. That does not mean every SCA preparation qualifies automatically: personnel, equipment, cleaning, documentation, and the assigned BUD still matter. If a scenario asks for a long BUD, look for whether the higher category’s required environment, testing, and controls are described.

What technicians should do in practice

Follow the facility’s current compounding policy and the pharmacist’s direction. Verify the preparation worksheet and label show the assigned BUD and storage condition. Do not extend a date because a product was refrigerated later, because a prior batch looked unchanged, or because a similar preparation had a longer date. Raise discrepancies before the CSP is released. The pharmacist or designated qualified person determines the category and BUD under current requirements.

A compact comparison

Think of the categories as a control-and-time ladder, not as a judgment of how important the drug is. Category 1 has a shorter BUD pathway and can be prepared in a qualifying SCA; Category 2 supports longer dating with the applicable cleanroom and procedural controls; Category 3 combines the longest pathway with more stringent ongoing controls and documentation. The precise limits depend on the current chapter’s tables, storage conditions, and preparation details. Exam questions commonly test the relationship rather than asking for an improvised BUD.

Common mistakes

Do not confuse CSP categories with USP <795> nonsterile compounding categories. Do not assume Category 3 simply means “more dangerous drug”; it concerns sterile preparation controls and BUD. Do not treat a BUD as a guarantee of potency through that date or a permission to ignore storage instructions. And do not use an old chart from a pre-2023 version of USP <797> as if it remained current. The revised chapter became official November 1, 2023.

PTCE takeaway

For a technician-level question, identify that USP <797> classifies CSPs as Categories 1, 2, and 3; connect longer BUDs with more robust controls; and defer exact category assignment and dating to current standards and authorized personnel. Certification does not itself qualify a technician to compound. Compounding work requires employer training, demonstrated competency, and compliance with state law and facility SOPs.

Operational detail to remember

A useful way to study a category question is to ask three questions in order: what environment is named, what controls are in place, and what BUD is being proposed? If the stem describes an SCA and a short period, that points toward the Category 1 pathway, but other chapter requirements still have to be satisfied. If it describes longer storage, look for the stronger category-specific controls and evidence rather than treating the requested date as proof. In practice, the pharmacist evaluates the ingredients, container, storage, preparation method, and supporting data. A technician checks that the approved worksheet and label agree, then raises a mismatch. This method works better than memorizing a single number because exact allowed periods can depend on the category and conditions, and the chapter can be revised.

Key points to carry into practice

• USP <797> organizes compounded sterile preparations (CSPs) into Category 1, Category 2, and Category 3. The categories connect the preparation environment and quality controls with the maximum supported beyond-use date (BUD). They are not simple labels for low, medium, and high risk, and a longer BUD requires stronger controls and evidence under the current chapter.
• Check the current official standard, payer guidance, or facility SOP for the exact requirement.
• Pause and escalate uncertainty instead of extending a date, bypassing a claim edit, or improvising a safety procedure.